Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
about
Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells.T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.T-cell receptor-engineered T cells for cancer treatment: current status and future directions.Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccinesQuantifiable predictive features define epitope-specific T cell receptor repertoires.Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy.Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients.T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire.T cell receptor β-chain repertoire analysis reveals the association between neoantigens and tumour-infiltrating lymphocytes in multifocal papillary thyroid carcinoma.Next-generation TCR sequencing - a tool to understand T-cell infiltration in human cancers.Similarity and difference in tumor-infiltrating lymphocytes in original tumor tissues and those of in vitro expanded populations in head and neck cancer.Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
P2860
Q37509860-B73B1FC0-D64C-40D5-8FA7-338E80B1BAC3Q38376433-2336968D-1F86-4BC3-B61D-64EF306CC6FCQ38767662-E2BB2C86-5E0D-4762-B6DA-AF5C5C038D7AQ39448911-D5BD3EC7-73D2-4603-A0A5-F007E35675C8Q40163819-BA38C0A2-14ED-48AD-B7B6-813E971A2CE8Q40242985-4BEF11E9-F6ED-42BB-8F19-906724AD7C2DQ41673084-3930FAF0-39F4-4246-B2F9-34DB818FEC0AQ47133741-33BAD47F-BE21-459C-AA15-D11648E4CBF7Q47155794-1A116143-8B62-4CDE-8C0A-787784A436CFQ48247566-B616A372-2FDF-4142-8BD0-D41E71729777Q48668844-520D380C-169D-4272-9056-FD6C119174B9Q49210435-6B63EB86-F3CF-4E97-B67F-DF7BBB4E840DQ49432766-BC9B474D-6BAE-424B-9FBB-A14EA71F7142Q52626852-C63CF400-E2C5-4619-B727-C2402D32A9B6Q57176182-7B0AA4F5-0387-44C1-82C0-F370605AC617
P2860
Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Tumor- and Neoantigen-Reactive ...... Their Frequency in Fresh Tumor
@en
Tumor- and Neoantigen-Reactive ...... heir Frequency in Fresh Tumor.
@nl
type
label
Tumor- and Neoantigen-Reactive ...... Their Frequency in Fresh Tumor
@en
Tumor- and Neoantigen-Reactive ...... heir Frequency in Fresh Tumor.
@nl
prefLabel
Tumor- and Neoantigen-Reactive ...... Their Frequency in Fresh Tumor
@en
Tumor- and Neoantigen-Reactive ...... heir Frequency in Fresh Tumor.
@nl
P2093
P2860
P1476
Tumor- and Neoantigen-Reactive ...... Their Frequency in Fresh Tumor
@en
P2093
Anna Pasetto
Bryan Howie
Daniel C Douek
Drew C Deniger
Harlan Robins
Jared Gartner
Jessica S Crystal
Katarzyna Trebska-McGowan
Maria R Parkhurst
Paul F Robbins
P2860
P304
P356
10.1158/2326-6066.CIR-16-0001
P50
P577
2016-06-28T00:00:00Z